Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.7B | 24.0B | 20.1B | 20.9B |
Cost of revenue | 14.2B | 22.5B | 18.3B | 19.5B |
Gross profit | -571.0M | 1.5B | 1.7B | 1.4B |
Operating expense | ||||
Research & development | 394.2M | 469.7M | 460.5M | 417.9M |
Selling general and admin | 1.1B | -2.1B | 3.4B | -468.1M |
Other operating expenses | 68.6M | 80.9M | 92.4M | 83.2M |
Operating income | -1.7B | -474.3M | 27.2M | -404.5M |
Non operating interest income | ||||
Income | 101.0M | 142.8M | 174.3M | 236.6M |
Expense | 245.4M | 227.9M | 220.3M | 209.4M |
Other income expense | — | — | — | — |
Pretax income | -1.7B | -2.4B | -1.4B | -3.5B |
Tax provision | -258.5M | -237.9M | -145.6M | -617.1M |
Net income | -1.5B | -2.1B | -1.3B | -2.9B |
Basic EPS | -0.2 | — | — | — |
Diluted EPS | -0.2 | — | — | — |
Basic average shares | 7.6B | — | — | — |
Diluted average shares | 7.6B | — | — | — |
EBITDA | -1.0B | 74.1M | -311.4M | -285.0M |
Net income from continuing op. | — | — | — | — |
Minority interests | 14.3M | 28.4M | 17.4M | 6.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |